Riverview Trust Company’s Concentrix CNXC Stock Holding History

Riverview Trust Company’s Portfolio CNXC Stock Details CNXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-198	Closed	-$13.1K	–	636
2024 Q1	$13.1K	Buy	+198	New	+$16.1K	0.01%	614
2023 Q4	–	Sell	-198	Closed	-$15.9K	–	197
2023 Q3	$15.9K	Buy	+198	New	+$15.5K	0.01%	500
2022 Q3	–	Sell	-92	Closed	-$12K	–	751
2022 Q2	$12K	Buy	+92	New	+$13.8K	0.01%	621

Other funds holding CNXC

GBL

Groupe Bruxelles Lambert Brussels, Belgium $62.2M AUM 57.6% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Impactive Capital New York City, New York $1.4B AUM 13.97% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

LAM

Lyrical Asset Management New York $7.88B AUM 36.5% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $199B AUM 37.98% 1-Year Est. Return

Riverview Trust Company's CNXC Position: Q2 2024 in Review

Riverview Trust Company sold out of Concentrix (CNXC) in Q2 2024, closing a stake of 198 shares — an estimated $13.1K sold.

Riverview Trust Company first reported a position in CNXC in Q2 2022 and held it in 3 quarters. The position peaked at $15.9K in Q3 2023. 297 funds tracked by Wall St. Rank hold CNXC as of Q2 2024.

Riverview Trust Company reported no remaining Concentrix position as of Q2 2024 after selling out during the quarter.
Riverview Trust Company sold 198 Concentrix shares in Q2 2024, an estimated $13.1K.
Riverview Trust Company first reported a position in Concentrix in Q2 2022 and held it in 3 quarters.
Riverview Trust Company's Concentrix position peaked at $15.9K in Q3 2023.
297 funds tracked by Wall St. Rank held Concentrix as of Q2 2024.

Based on Riverview Trust Company's 13F filing for Q2 2024, filed 16 Jul 2024.